CX Institutional boosted its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 5.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,852 shares of the financial services provider's stock after buying an additional 1,648 shares during the quarter. CX Institutional's holdings in Marsh & McLennan Companies were worth $8,505,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC lifted its stake in Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock worth $1,856,000 after acquiring an additional 2,960 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at about $10,366,000. Golden State Wealth Management LLC bought a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $41,000. Kestra Private Wealth Services LLC increased its holdings in Marsh & McLennan Companies by 9.3% during the fourth quarter. Kestra Private Wealth Services LLC now owns 10,999 shares of the financial services provider's stock valued at $2,336,000 after buying an additional 937 shares during the period. Finally, Savant Capital LLC raised its stake in Marsh & McLennan Companies by 3.5% in the fourth quarter. Savant Capital LLC now owns 9,051 shares of the financial services provider's stock worth $1,922,000 after buying an additional 310 shares in the last quarter. 87.99% of the stock is currently owned by institutional investors.
Marsh & McLennan Companies Stock Performance
Shares of MMC stock traded down $2.21 during trading hours on Friday, hitting $217.19. The company's stock had a trading volume of 1,574,516 shares, compared to its average volume of 1,933,764. The stock has a market cap of $107.02 billion, a PE ratio of 26.52, a price-to-earnings-growth ratio of 2.70 and a beta of 0.83. The company has a 50 day moving average of $226.47 and a 200 day moving average of $225.50. Marsh & McLennan Companies, Inc. has a 12-month low of $207.21 and a 12-month high of $248.00. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.44.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The financial services provider reported $3.06 earnings per share for the quarter, beating analysts' consensus estimates of $3.02 by $0.04. The business had revenue of $6.70 billion during the quarter, compared to analyst estimates of $7.08 billion. Marsh & McLennan Companies had a return on equity of 32.60% and a net margin of 16.60%. During the same quarter last year, the business posted $2.89 EPS. On average, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently issued reports on MMC shares. Wells Fargo & Company lifted their price target on Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. Barclays raised their target price on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. UBS Group upped their price target on Marsh & McLennan Companies from $259.00 to $261.00 and gave the stock a "buy" rating in a research report on Wednesday, April 9th. Jefferies Financial Group boosted their target price on Marsh & McLennan Companies from $237.00 to $244.00 and gave the stock a "hold" rating in a research note on Friday, April 11th. Finally, Keefe, Bruyette & Woods decreased their price objective on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating for the company in a research report on Monday, April 21st. Two analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $241.93.
Read Our Latest Analysis on MMC
Insider Activity at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO Dean Michael Klisura sold 9,569 shares of Marsh & McLennan Companies stock in a transaction on Monday, March 31st. The shares were sold at an average price of $245.00, for a total value of $2,344,405.00. Following the completion of the transaction, the chief executive officer now owns 20,935 shares of the company's stock, valued at approximately $5,129,075. The trade was a 31.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Paul Beswick sold 2,237 shares of the firm's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $246.00, for a total value of $550,302.00. Following the sale, the senior vice president now owns 13,522 shares in the company, valued at $3,326,412. This trade represents a 14.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.
About Marsh & McLennan Companies
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Further Reading

Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.